Reported Standalone quarterly numbers for Suven Life Sciences are:
Net Sales at Rs 1.61 crore in December 2024 down 34.31% from Rs. 2.45 crore in December 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 13.27 crore in December 2024 down 178.31% from Rs. 4.77 crore in December 2023.
EBITDA stands negative at Rs. 11.73 crore in December 2024 down 274.76% from Rs. 3.13 crore in December 2023.
Suven Life Sci shares closed at 121.07 on January 23, 2025 (NSE) and has given -9.73% returns over the last 6 months and 10.41% over the last 12 months.
Story continues below Advertisement
| Suven Life Sciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'24 | Sep'24 | Dec'23 | | Net Sales/Income from operations | 1.61 | 2.57 | 2.45 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 1.61 | 2.57 | 2.45 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 4.87 | 5.20 | 4.32 | | Depreciation | 1.53 | 1.46 | 1.60 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | 8.26 | 9.09 | 6.19 | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 1.78 | 1.92 | 1.14 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -14.83 | -15.09 | -10.80 | | Other Income | 1.57 | 4.03 | 6.07 | | P/L Before Int., Excpt. Items & Tax | -13.26 | -11.06 | -4.73 | | Interest | 0.01 | 0.02 | 0.04 | | P/L Before Exceptional Items & Tax | -13.27 | -11.07 | -4.77 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -13.27 | -11.07 | -4.77 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -13.27 | -11.07 | -4.77 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -13.27 | -11.07 | -4.77 | | Equity Share Capital | 21.81 | 21.81 | 21.81 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.61 | -0.51 | -0.22 | | Diluted EPS | -0.61 | -0.51 | -0.22 | | EPS After Extra Ordinary | | Basic EPS | -0.61 | -0.51 | -0.22 | | Diluted EPS | -0.61 | -0.51 | -0.22 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
